General Information
Revision date
2019-07-01
Product name
Erlotinib, Free Base
CAS No.
183321-74-6
Icons in SDS
Company Information
company name
LC Laboratories
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302+H312+H332
Hazard statements
Code
Statements
H302+H312+H332
Harmful if swallowed, in contact with skin or if inhaled
Section 2
Hazard statements
pharmaceutically active substance Substance Class Identifier: Tumorigen; Drug; Human Data Harmful if swallowed May be harmful if inhaled or through skin absorption Ingestion may result in rash, dry skin, pruritus (itch), diarrhea, nausea, vomiting, stomach pain, anorexia (decreased appetite), weight loss, fatigue, dyspnea (shortness of breath), stomatitis (inflammation/ulceration of the mucous membranes lining of the mouth), cough, liver failure, kidney failure, increased bleeding rates, gastrointestinal perforation, and corneal perforation or ulceration May be irritating to skin, eyes, mucous membranes, and upper respiratory tract H302+312+332 - Harmful if swallowed, in contact with skin or if inhaled
Precautionary statements
P2562 - Do not get in eyes, on skin or on clothing WARNING For Laboratory Research Use Only
